Analysts delivered a mixed verdict across sectors on Thursday, with retail winners and a notable pharma downgrade dominating the tape.
Ross Stores was the clear standout. Two separate target price upgrades landed within hours of each other. The consensus average target rose to $264.50, up from $257.50. The $75B off-price retailer benefits from a defensive consumer trade that analysts see holding firm.
Merck took the hardest hit. A fresh downgrade pushed the pharma giant's consensus from Hold to Sell territory. The average target dropped to $147.77 from $142.46 prior. At a $375B market cap, the move carries weight. Merck's pipeline concerns and patent cliff pressures remain a headwind for bulls.
Deere & Company got a boost. The agriculture and construction equipment maker saw its consensus target climb to $654.79 from $645.22. That's a near $10 increase. Improved farm income expectations and resilient equipment demand appear to be driving the upgrade in views.
Walmart moved the other way. Its consensus target slipped to $133.13 from $137.93. Margin pressure and elevated valuations may be weighing on analyst enthusiasm for the retail giant.
Nordson attracted attention with a $15 jump in average target price, rising to $331.86 — one of the sharpest percentage moves in the batch.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
